高级检索
当前位置: 首页 > 详情页

Molecular analysis and clinical diversity of distal hereditary motor neuropathy

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Neurology, Peking University Third Hospital, Beijing [2]Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing [3]Department of Neurology, China-Japan Friendship Hospital, Beijing [4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China
出处:
ISSN:

关键词: amyotrophic lateral sclerosis Charcot-Marie-Tooth hereditary motor neuropathies

摘要:
Background and purpose Distal hereditary motor neuropathies (dHMNs) are a clinically and genetically heterogeneous group of disorders. The purpose of this study was to identify the genetic distribution of dHMNs in a large cohort of Chinese patients and provide insight into the underlying common pathophysiology of dHMNs. Methods Multi-gene panel testing or whole-exome sequencing was performed in 70 index patients with clinically diagnosed dHMN between January 2007 and December 2018. The clinical features, Charcot-Marie-Tooth (CMT) neuropathy scores and electrophysiological data at diagnosis were recorded. Results Twenty-four causative mutations were identified in 70 index patients with dHMN (34.3%). Mutation in the HSPB1 gene was the most common cause of dHMN. Some CMT genes (MPZ, SH3TC2, GDAP1) were found to be related to dHMN with minor sensory involvement. Patients with a dHMN-plus phenotype (distal motor neuropathy and additional neurological deficits) carried variants in genes related to hereditary spastic paraplegia, amyotrophic lateral sclerosis and spinal muscular atrophy (FUS, KIF5A, KIF1B, ZFYVE26, DNAJB2). Conclusions Comprehensive genetic testing of dHMN patients allows for identification of the pathogenic mutation in one-third of cases. Pure motor neuropathies and motor neuropathies with minor sensory involvement share many genes with CMT disease. Causes for dHMN-plus phenotypes overlap with motor neuron disease.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 神经科学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 神经科学
JCR分区:
出版当年[2018]版:
Q1 CLINICAL NEUROLOGY Q1 NEUROSCIENCES
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Department of Neurology, Peking University Third Hospital, Beijing [2]Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing
通讯作者:
通讯机构: [1]Department of Neurology, Peking University Third Hospital, Beijing [2]Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing [4]Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China [*1]No. 49, North Garden Road, Haidian District, Beijing 100191, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)